Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

All antipsychotics currently used in clinic block D2 dopamine receptors. Trace amine-associated receptor 1 is emerging as a new therapeutic target for schizophrenia and several other neuropsychiatric disorders. SEP-363856 (International Nonproprietary Name: Ulotaront) is an investigational antipsych...

Full description

Bibliographic Details
Main Authors:	Savelii R. Kuvarzin, Ilya Sukhanov, Kirill Onokhin, Konstantin Zakharov, Raul R. Gainetdinov
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Biomedicines
Subjects:	SEP-363856 antipsychotic agents dopamine schizophrenia ulotaront trace amine-associated receptor 1
Online Access:	https://www.mdpi.com/2227-9059/11/7/1977

Similar Items

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
by: Yu-Luan Chen, et al.
Published: (2023-03-01)

Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856
by: Veronica Begni, et al.
Published: (2021-04-01)

The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
by: Xia Ren, et al.
Published: (2022-04-01)

Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
by: Lingzhi Liang, et al.
Published: (2022-04-01)

Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders
by: Mikhail Krasavin, et al.
Published: (2022-11-01)

Emerging trends in antipsychotic and antidepressant drug development: Targeting nonmonoamine receptors and innovative mechanisms
by: Hitoshi Osaka, et al.
Published: (2023-12-01)

Evaluation of OCT2‐mediated drug–drug interactions between ulotaront and metformin in subjects with schizophrenia
by: Guangqing Xiao, et al.
Published: (2024-04-01)

Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-<i>N</i>-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders
by: Mikhail Krasavin, et al.
Published: (2022-09-01)

Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis
by: Evgeniya V. Efimova, et al.
Published: (2022-04-01)

Trace Amine-Associated Receptors and Monoamine-Mediated Regulation of Insulin Secretion in Pancreatic Islets
by: Anastasia N. Vaganova, et al.
Published: (2023-11-01)

The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype
by: Anastasia N. Vaganova, et al.
Published: (2023-09-01)

Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
by: Ilya Sukhanov, et al.
Published: (2018-04-01)

Public Transcriptomic Data Meta-Analysis Demonstrates TAAR6 Expression in the Mental Disorder-Related Brain Areas in Human and Mouse Brain
by: Anastasia N. Vaganova, et al.
Published: (2022-09-01)

Genetic Deletion of Trace-Amine Associated Receptor 9 (TAAR9) in Rats Leads to Decreased Blood Cholesterol Levels
by: Ramilya Z. Murtazina, et al.
Published: (2021-03-01)

Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats
by: Ilya S. Zhukov, et al.
Published: (2022-12-01)

Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets
by: Anthony A. Grace, et al.
Published: (2023-08-01)

Protein Metabolism Changes and Alterations in Behavior of Trace Amine-Associated Receptor 1 Knockout Mice Fed a High-Fructose Diet
by: Sergey A. Apryatin, et al.
Published: (2023-02-01)

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
by: Pavel Mohr, et al.
Published: (2022-01-01)

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
by: Nina Dedic, et al.
Published: (2021-12-01)

PISA y las metas sectoriales de la SEP
by: Joaquín Quesada García, et al.
Published: (2010-12-01)

Bioconversion of Tyrosine and Tryptophan Derived Biogenic Amines by Neuropathogenic Bacteria
by: Aneela Taj, et al.
Published: (2018-02-01)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
by: Davide Amato, et al.
Published: (2019-05-01)

Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
by: Liisa Leppik, et al.
Published: (2018-04-01)

Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice
by: Ilya S. Zhukov, et al.
Published: (2021-07-01)

Palladium-Catalyzed Amination of Dichloroquinolines with Adamantane-Containing Amines
by: Irina P. Beletskaya, et al.
Published: (2013-02-01)

Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
by: Yongjian Chen, et al.
Published: (2022-10-01)

Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma
by: Anastasia N. Vaganova, et al.
Published: (2022-01-01)

EZ-SEP: Extended Z-SEP Routing Protocol with Hierarchical Clustering Approach for Wireless Heterogeneous Sensor Network
by: Zhanserik Nurlan, et al.
Published: (2021-02-01)

ANALYZING THE HETEROGENEOUS AND HOMOGENEOUS WSNS IN THE TERM OF TOTAL ENERGY CONSUMPTION
by: Mahmood F. Mosleh, et al.
Published: (2016-07-01)

From a Pathophysiological Concept to a New Drug
by: G. Németh
Published: (2022-06-01)

A esquizofrenia e seu tratamento farmacológico
by: Cilene Rejane Ramos Alves, et al.

Acute dystonia induced by quetiapine: a case report
by: Sachin Ratan Gedam, et al.
Published: (2015-01-01)

Amines : synthesis, properties, and applications /
by: Lawrence, Stephen A., 1960-
Published: (2004)

Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer
by: Michał Czerwiński, et al.
Published: (2021-10-01)

A case of levosulpiride-induced tardive dyskinesia
by: Soumitra Ghosh, et al.
Published: (2019-06-01)

Expression Pattern of Trace Amine-Associated Receptors during Differentiation of Human Pluripotent Stem Cells to Dopaminergic Neurons
by: Nataliia V. Katolikova, et al.
Published: (2023-10-01)

Studio sulla contestualizzazione dell’induzione ipnotica attraverso la latenza dei potenziali evocati somatosensoriali.
by: Matilde Debenedetti, et al.
Published: (2022-12-01)

Physiologically active amines in common fruits and vegetables /
by: 432134 Udenfriend, Sidney, et al.

Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
by: Aleksander A. Aleksandrov, et al.
Published: (2019-05-01)

Experimental protocol for the study of One-pot amination of Cyclohexanone-to-secondary amines over Carbon-supported Pd
by: Luis E. Arteaga-Pérez, et al.
Published: (2021-01-01)